Skip to content

Endocrine and Neural Control of Eating in Women

Steroid Hormones in the Peripheral and Central Control of Eating in Women - Physiological Reactions to Eating in Normal- and Overweight Women

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02994420
Enrollment
50
Registered
2016-12-15
Start date
2016-07-31
Completion date
2019-12-31
Last updated
2022-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Body Weight, Obesity

Keywords

Obesity, Menstrual Cycle, Gonadal Steroid Hormones, Satiety Response, Glucagon-Like Peptide 1, Cholecystokinin, Magnetic Resonance Imaging

Brief summary

The purpose of this study is to better understand how female sex hormones influence the food intake in the gut system through the release of satiety hormones as well as through central regulative mechanisms in the brain that subsequently contribute to the control of eating in healthy women at different stages of the ovarian cycle.

Detailed description

Obesity and the associated severe consequences for health, i.e. cardiovascular diseases or Diabetes Type 2 reach the world-wide level of an epidemic with excessive eating as major cause of this development. Study results of veterinary physiology as well as in women let assume that steroid hormones, such as estrogen or progesterone are highly involved in the regulation of eating behavior and the female body weight. This connection is underpinned with the fact that prevalence of adiposity is increased in women in comparison to men in the United States, Switzerland and further countries. A better understanding of the underlying regulatory mechanisms, which in turn influence the food intake in the gut system through the release of satiety hormones as well as through central regulative mechanisms in the brain, provides important foundation in long-term development of new prophylactic and therapeutic options in reduction and prevention of obesity. This gets even more important, as current therapeutic options - beside bariatric surgery - could only show limited success. Satiety is a process in the brain that leads to a meal being ended, whereby the ingested food causes a reflexive negative feedback mechanism. This mechanism is both fundamentally and specifically in the acute situation strongly influenced through subjective parameters, e.g. eating desires, socio-cultural factors, current social circumstances and individual relation towards eating. Furthermore, food intake is also influenced by genetic factors, whereas e.g. TaqIA1 allele is known to be associated with obesity. According to current knowledge, regulation takes place on peripheral as well as on central level, whereas not only steroid hormones but also satiety hormones - especially cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1) - are involved on both levels. The current study aims to examine the connection of steroid hormones, gastrointestinal satiety hormones and neuronal activity in the brain through fMRI. Through the obtained data, the interaction between defined hormone constellations, gastrointestinal satiety hormones and the activation of specific brain areas in obese and normal-weight women should be evaluated. The study design involves the comparison of subjective, hedonic evaluation of different flavoured liquids with different caloric content each through a rating scale as well as objective peripheral (release of CCK and GLP-1) and central (activation of involved brain centres through fMRI) regulation processes in fasted and fed condition of each woman in the two study groups (obese and normal-weighted) in late follicular compared with the luteal phase of ovarian cycle.

Interventions

None listed

Sponsors

University Hospital, Zürich
CollaboratorOTHER
University of Zurich
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Physically and psychiatrically healthy women * Stable body weight (no changes ≥ 5 kg in past year) * Age 18-35 years * Regular menses (26-32 d cycles) * Right-handed * German language fluency * Signed informed consent

Exclusion criteria

* Life history of eating disorders * Aversion to the test foods * Pacemaker or neurostimulator * Hearing aid * Surgery to head or heart * Potential metal parts in body (pacemakers, metal splinters, gun wounds, shrapnel or surgical clips) * Neurological or psychiatric problems or serious brain injury (such as alcohol or drug abuse, depression, schizophrenia, bipolar disorders, anxiety disorder, claustrophobia, Parkinson's disease, multiple sclerosis, epilepsy) * High blood pressure, low blood pressure, history of heart disease, irregular heart rate * Emphysema, chest or respiratory problems (including difficulty breathing through the nose) * Pregnancy, nursing or pregnancy planned in next three months * History of gall bladder disease or symptoms (right upper abdominal quadrant pain after meals) * Polycystic ovary syndrome, as gauged by testosterone levels * Allergy or sensitivity to lactose * Allergy to quinine * Current or previous malignancies * History of difficult blood sampling

Design outcomes

Primary

MeasureTime frameDescription
fMRI responses to food cues90 min per study dayChange in blood oxygen dependent signal (BOLD) in exposure to visual food cues will be measured during a fMRI scan and the difference between responses in the fed condition compared with those in the fasted condition
Change in CCK (satiety hormone) response curve30 min per study dayBlood samples will be collected at 0, 5, 10, 15, 20, 25, 30 min following the ingestion of the meal at each experimental visit, giving a specific curve and analyzed to determine the gut hormone responses. The results will be compared between fast and fed condition, between obese and normal weight women and depending on ovarian cycle phase.
Change in GLP-1 (satiety hormone) response curve30 min per study dayBlood samples will be collected at 0, 5, 10, 15, 20, 25, 30 min following the ingestion of the meal at each experimental visit, giving a specific curve and analyzed to determine the gut hormone responses. The results will be compared between fast and fed condition, between obese and normal weight women and depending on ovarian cycle phase.

Secondary

MeasureTime frameDescription
Hedonic ratings20 min per study daySubjective ratings of flavor pleasantness will be collected using psychophysical rating scales (gLMS)
Change in food preference indicating motivation to purchase food items20 min per study dayThe willingness-to-pay task measures the motivation to obtain food on a gLMS scale. The results will be compared between fast and fed condition, between obese and normal weight women and depending on ovarian cycle phase.
Subjective sensory ratings20 min per study daySubjective ratings of hunger sensation will be collected using psychophysical rating scales (gLMS)
Change in food preference indicating motivation to exert effort20 min per study dayThe willingness-to-exert-effort task measures the motivation to obtain food on a gLMS scale. The results will be compared between fast and fed condition, between obese and normal weight women and depending on ovarian cycle phase.
Dietary intake30 min per study dayMeasure of the calorie intake

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026